Literature DB >> 6875709

Intrahepatic "cholestasis facies": is it specific for Alagille syndrome?

R J Sokol, J E Heubi, W F Balistreri.   

Abstract

In 1975 Alagille described in the English literature a syndromatic form of intrahepatic biliary hypoplasia associated with characteristic facial features (prominent forehead, deep-set eyes, mild hypertelorism, straight nose, and small pointed chin). To test the specificity of the facies for Alagille syndrome, close-up facial photographs of 15 children and young adults with various forms of intrahepatic cholestasis (including seven with Alagille syndrome) were examined by 13 pediatric hepatologists from the United States and Canada and by Dr. Alagille and eight of his co-workers from France, without knowledge of the individual diagnoses. Each examiner was asked to identify the patients with facies characteristic for Alagille syndrome. Fifty-one percent of the U.S./Canadian group's matchings and 49% of the French group's matchings of facies to underlying liver disease (presence or absence of Alagille syndrome) were incorrect. The sensitivity of the facies for diagnosing Alagille syndrome was 54% and 32%, the specificity 44% and 68%, and the predictive value 46% and 47% based on the U.S./Canadian and French groups, respectively. "Cholestasis facies" does not appear specific for Alagille syndrome; rather, it seems to be a general feature of congenital intrahepatic cholestatic liver disease.

Entities:  

Mesh:

Year:  1983        PMID: 6875709     DOI: 10.1016/s0022-3476(83)80345-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  Alagille syndrome: pathogenesis, diagnosis and management.

Authors:  Peter D Turnpenny; Sian Ellard
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

2.  Alagille syndrome in a Vietnamese cohort: mutation analysis and assessment of facial features.

Authors:  Henry C Lin; Phuc Le Hoang; Anne Hutchinson; Grace Chao; Jennifer Gerfen; Kathleen M Loomes; Ian Krantz; Binita M Kamath; Nancy B Spinner
Journal:  Am J Med Genet A       Date:  2012-04-09       Impact factor: 2.802

Review 3.  Alagille syndrome.

Authors:  I D Krantz; D A Piccoli; N B Spinner
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

4.  Segregation analysis of Alagille syndrome.

Authors:  S Dhorne-Pollet; J F Deleuze; M Hadchouel; C Bonaïti-Pellié
Journal:  J Med Genet       Date:  1994-06       Impact factor: 6.318

Review 5.  The Alagille syndrome (arteriohepatic dysplasia).

Authors:  R F Mueller
Journal:  J Med Genet       Date:  1987-10       Impact factor: 6.318

Review 6.  Alagille syndrome.

Authors:  Michelle Hadchouel
Journal:  Indian J Pediatr       Date:  2002-09       Impact factor: 1.967

7.  Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia).

Authors:  R Habib; J P Dommergues; M C Gubler; M Hadchouel; M Gautier; M Odievre; D Alagille
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

Review 8.  Medical and dental management of Alagille syndrome: a review.

Authors:  Adam Berniczei-Royko; Renata Chałas; Iwona Mitura; Katalin Nagy; Elżbieta Prussak
Journal:  Med Sci Monit       Date:  2014-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.